Am J Ind Med by Kreiss, Kathleen
Work-Related Spirometric Restriction in Flavoring
Manufacturing Workers
Kathleen Kreiss, MD
Background Flavoring-exposed workers are at risk for occupational lung disease.
Methods We examined serial spirometries from corporate medical surveillance of
ﬂavoring production workers to assess abnormality compared to the U.S. population;
mean decline in forced expiratory volume in one second (FEV1) and forced vital capacity
(FVC); and excessive declines in FEV1.
Results Of 106workers, 30 had spirometric restriction, 3 had obstruction, 1 had both, and
13 (of 70, 19%) had excessive declines in FEV1. The adjusted prevalence of restriction was
3.7 times expected. Employees with higher potential for ﬂavorings exposure had 3.0 times
and 2.4 times greater average annual declines in FEV1 and FVC respectively, and had 5.8
times higher odds of having excessive FEV1 declines than employees with lower potential
for exposure.
Conclusion Exposure-related spirometric abnormalities consistent with a restrictive
process evolved during employment, suggesting that exposures in ﬂavoring production are
associated with a range of pathophysiology.Am. J. Ind. Med. 57:129–137, 2014. Published
2013. This article is a U.S. Government work and is in the public domain in the USA.
KEY WORDS: ﬂavorings; diacetyl; hydrogen sulﬁde; spirometry; spirometric
restriction; excessive decline
INTRODUCTION
Cases of biopsy-conﬁrmed constrictive bronchiolitis
have occurred throughout the microwave popcorn and
ﬂavoring manufacturing industries [NIOSH, 2011b]. Recent-
ly, constrictive bronchiolitis clusters have been reported in
other food production, such as cookie doughmanufacture and
coffee roasting and ﬂavoring [Cavalcanti et al., 2012; CDC,
2013]. Such cases have been sentinels of risk of occupational
lung disease among co-workers that have often had excesses
of abnormal spirometry [Kreiss et al., 2002]. In the
microwave popcorn industry, abnormal spirometry was
associated with exposure to inhaled diacetyl (2,3-butane-
dione), a main ingredient of artiﬁcial butter ﬂavorings [Kreiss
et al., 2002]. Because sentinel cases were recognized as
having clinical or biopsy-conﬁrmed constrictive bronchioli-
tis, investigators concentrated on ﬁxed airways obstruction,
but restrictive spirometry abnormalities and mixed restriction
and obstruction also commonly occurred in these plants
[Kreiss, 2012]. The full spectrum of occupational lung
disease associated with diacetyl or other ﬂavoring exposures
is still under investigation.
In 2008, the National Institute for Occupational Safety
and Health (NIOSH) received a request for an evaluation of
respiratory health risks at a ﬂavoring manufacturing facility
[NIOSH, 2011a]. This facility used batch processes to
produce a variety of ﬂavor formulations in liquid, paste, and
powder form. Flavors produced included butter, buttermilk,
cheese, sour cream, coffee, orange, blueberry, raspberry,
grape, beef, chicken, and ﬁsh, among many others. Diacetyl
was used in producing butter, cheese, nut, and berry ﬂavors.
The facility used many chemicals on the 2004 list of priority
potential respiratory hazards generated by the Flavor and
Extract Manufacturers Association (FEMA) (Table I)
[FEMA, 2004]. A subsequent compliance investigation by
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the Indiana Occupational Safety and Health Administration
(IOSHA) found additional chemicals, such as dimethyl
sulﬁde, ethanol, 6-methylcoumarin, and hydrogen sulﬁde, the
last at concentrations immediately dangerous to life and
health [IOSHA, 2012].
The NIOSH health hazard evaluation documented an
impressive increased cross-sectional prevalence of abnormal
restrictive spirometry compared to the general U.S. popula-
tion. This ﬁnding suggestive of restrictive lung disease
contrasted with the excess of obstructive spirometric
abnormalities seen in many other ﬂavoring-exposed work-
forces [NIOSH, 2011a]. This paper derives from the NIOSH
evaluation, supplemented by later environmental information
and recoding of smoking status information, which was
incomplete in the previous report. The objective of this study
was to examine routine medical surveillance data collected by
the company to determine whether the excess abnormalities
were associated with indices of exposure reﬂected in
workers’ job histories and areas of production work. Since
the company surveillance data was longitudinal in nature, we
had the opportunity to look at declines of lung function during
employment in production workers as individuals and in
subgroups by job title and area. We hypothesized that
statistically different distributions of spirometric abnormali-
ties, including abnormal declines in lung function over time,
within the production workforce existed. Such work-related
differences would likely implicate work exposures as
responsible for excess abnormalities.
Exposure Background
Industrial hygiene measurements of diacetyl conducted
for the company between 2004 and 2007 were limited to 14
area and 10 personal samples taken when diacetyl-containing
products were being prepared in six areas. The NIOSH 2557
method used for diacetyl measurement was subsequently
shown to result in underestimation in relation to absolute
humidity and days to extraction of the samples in the
laboratory [NIOSH, 2011a]. The maximum 8-hr time-
weighted average (TWA) concentration of diacetyl was
10.17 parts per million (ppm) in an area sample in liquid
compounding; a personal breathing zone sample in X-Oil
(process ﬂavors, adjacent to liquid compounding) was as high
as 3 ppm, but insufﬁcient data regarding sampling volume
and time were available to calculate a TWA. For comparison,
NIOSH has proposed a recommended diacetyl exposure limit
of 0.005 ppm, with a 15-min short-term exposure limit
(STEL) of 0.025 ppm [NIOSH, 2011b]. Other sampled
analytes included acetaldehyde, acetic acid, benzyl alcohol,
butyric acid, ethyl acetate, ethyl alcohol, phosphoric acid,
respirable dust, and total dust, all of which were found at
levels below occupational guideline limits, when available. In
2008–2009, 71 area samples in 10 locations and 45 personal
breathing zone measurements in 8 areas were conducted for
the company using updated sampling/analytical methods for
diacetyl that are not affected by humidity. All areas sampled
(including laboratory, packaging, and warehouse) had
detectable levels of diacetyl, at 8-hr TWA concentrations
up to 2.9 ppm for area samples and 1.9 ppm for personal
samples [NIOSH, 2011a].
In 2011–2012, IOSHAmeasured diacetyl concentrations
in the factory when diacetyl was suspected to be present, with
28 results based on measurements from 9 to 92min in
duration that exceeded the American Conference of
Governmental Industrial Hygienists’ (ACGIH) guidance
not to exceed 0.02 ppm as a 15-min STEL or 0.01 ppm as
an 8-hr TWA diacetyl concentration [IOSHA, 2012].
Calculated diacetyl concentrations, adjusted assuming zero
exposure for the balance of the time not sampled, ranged up to
9.19 ppm short-term (based on 13min of sampling) and
0.52 ppm for an 8-hr average (based on 55min of sampling).
Concentrations were higher during the actual sampled
periods (10.66 and 4.56 ppm, respectively). These diacetyl
concentrations occurred on 5 days over 2 months and were in
the X-Oil and packaging areas. The settlement of the
compliance citations in January 2013 eliminated four of the
TABLE I. Chemicals (IncludingThose on the 2004 FEMAHigh Priority List for Respiratory Hazards) Used at the FlavoringManufacturing Facility by
Frequency of Use in June 2008
Near daily use Frequent use Less Frequent use Rare use
Acetaldehyde Furfural Formic acid Ammonium sulfide
Acetic acid Limonenea Isobutyraldehyde Ethyl acrylate
Acetoin Propionic acid Isobutyric acid Hydrogen sulfide
Benzaldehyde Starter distillatea Methyl mercaptan 2-pentenal
Butyric acid Propionaldehyde Phenol
Diacetyl Trimethylamine Piperidine
Phosphoric acid Valeraldehyde Pyridine
Pyrrolidine
aNot on 2004 Flavoring and ExtractManufacturers Association priority list as potential respiratory hazards.
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28 excessive diacetyl measurements after comparison to a
2009 OSHA proposed Permissible Exposure Limit (PEL) of
0.2 ppm as a STEL and 0.05 ppm as an 8-hr TWA (including
two packaging worker measurements) and eliminated an
additional six excessive diacetyl measurements from an
acetoin pour which was deemed not to be a source of diacetyl
[IOSHA, 2012].
An unexpected ﬁnding in the IOSHA compliance
investigation was hydrogen sulﬁde concentrations that were
above the ceiling permissible exposure limit of 20 ppm and
above the 100 ppm value immediately dangerous to life or
health. Appropriate personal respiratory protection was not
provided, nor was evacuation required when hydrogen sulﬁde
exposure monitors alarmed. These exposures, measured at
125, 172, 200, and 200 ppm, occurred for compounders in a
reactions/savory area where employees described emanation
of hydrogen sulﬁde when ammonium sulﬁde was added to
sulfur-containing amino acids in making beef, chicken, and
crab ﬂavors. IOSHA measured acetic acid in the liquid
compounding area at levels of 28.5 and 54.7 ppm as 15-min
time-weighted averages, both exceeding the ACGIH STEL of
15.0 ppm [IOSHA, 2012].
METHODS
Population
The population was a retrospective cohort study of 112
production workers who had participated in spirometric
medical surveillance arranged by the ﬂavoring company
during the 2004–2009 interval for the purpose of medical
clearance for respirator use. The company had approximately
115 production employees and 100 ofﬁce workers in 2008,
and the retrospective cohort study of those with spirometry
measurements included at least 4 former workers at that time.
We abstracted age, height, weight, and smoking status (when
available) as non-smoker, former smoker or current smoker,
from all spirometry records supplied by the company’s
medical contractor for employees who participated in the
production worker medical surveillance program. In con-
ducting a public health investigation, NIOSH investigators
had authority to receive personally identiﬁable information
subject to the Health Insurance Portability andAccountability
Act, which permits medical providers to disclose protected
health information without a patient’s written authorization to
public health authorities [U.S. Code of Federal Regulations,
2002]. From these records, we classiﬁed employees as having
been an ever-smoker if they had been a current or former
smoker at any testing session.
We obtained work history information from company
personnel records that indicated job title and area with start
dates for each job title and date of termination, if the worker
was no longer employed. We calculated tenure at work from
these employment records. The company identiﬁed 12 areas:
administration, dry blend, extract and distillation, liquid
compounding, maintenance, packaging, process ﬂavors,
sample ordering, spray dry, warehouse, quality control, and
research and development. We combined the last two areas
into one category for analyses because of the small numbers in
these two areas and the likely similar levels of exposure to
ﬂavoring chemicals. Based on information about where liquid
and dry ﬂavorings were produced from a site visit in 2008, we
a priori assigned employees in the following areas to a
category of higher potential for exposure to ﬂavoring
chemicals: dry blend, extract and distillation, liquid com-
pounding, process ﬂavors, and spray dry.Workerswho did not
work in these areas, including packaging, were assigned to the
lower category of ﬂavorings exposure. We categorized the
work history information in four different ways: (1) currently
working in an area; (2) ever worked in an area; (3) currently
working in areas with higher potential for exposure; and (4)
ever worked in areas with higher potential for exposure.
Spirometry Records Evaluation
We evaluated the quality of 369 spirometry records from
112 employees with test sessions dating from July 6, 1998 to
August 25, 2009, including examination of curves for all
efforts in a test session. Two-thirds of the spirometry tests
were performed using an EasyOneTM spirometer (ndd
Medical Technologies, Andover, MA); most test sessions
included a quality grade. When reports did not include a
quality grade (as was the case for 29 tests performed using an
EasyOne spirometer and for 119 tests performed with another
type of spirometer), we graded spirometry using the EasyOne
Spirometry EasyGuide criteria from the version 4.0 manual.
Spirometry tests graded A or B had at least three acceptable
expiratory efforts, and measurements of forced expiratory
volume in one second (FEV1) and forced vital capacity
(FVC) matched within 200ml or less. Spirometry tests
graded C had at least two acceptable efforts, and measure-
ments for FEV1 and FVC matched within 250ml or less.
Spirometry tests graded D had only one acceptable effort, or
the two best acceptable measurements did not meet the
250ml criterion for repeatability. Spirometry graded F had no
acceptable efforts. There were four tests performed with a
different model spirometer that did not have enough
information about each individual expiratory effort to allow
for a quality grade to be assigned, and these data were not
used. Where recorded heights differed for individuals with
more than one spirometry report, we used the most frequently
recorded height value (mode) to interpret spirometry results;
when there was no modal height value, we used the mean of
the reported heights.
We interpreted spirometry results with A, B, or C quality
grade as normal or abnormal in relation to U.S. population
reference equations [Hankinson et al., 1999]. If a test had a D
quality grade but documented normal ventilatory function,
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we interpreted it as normal; if abnormal or F quality, the test
was uninterpretable. We deﬁned obstructive spirometric
abnormalities as having FEV1 and FEV1/FVC below the
lower limits of normal; restrictive abnormalities as having
FVC below the lower limit of normal; and mixed obstructive
and restrictive as having FEV1, FVC, and FEV1/FVC all
below the lower limits of normal.We further categorized such
abnormalities as mild, moderate, moderately severe, severe,
or very severe [Pellegrino et al., 2005].
We compared the prevalence of an abnormal restrictive
pattern of spirometry with the prevalence that would
be expected in the U.S. general population with the same
distributions of age (less than 40 years and 40 or older), sex,
race, ethnicity, ever smoking (yes, no), and body mass index
(less than 25, 25 to less than 30, and 30 or greater kg/m2).
The U.S. population prevalences were based on the third
National Health and Nutrition Examination Survey [National
Center for Health Statistics, 1996]. We used SAS1 (version
9.2, SAS Institute, Inc., Cary, NC) statistical software to
analyze the data and chose a probability (P) less than or
equal to 0.05 as a criterion of statistical signiﬁcance and
0.05<P< 0.1 as showing a trend with marginal statistical
signiﬁcance.
Changes in lung function over time
For each employee having spirometry on more than one
occasion, we estimated change in serial lung function using
multivariate linear regression of both all FEV1 and all FVC
measurements of A, B, or C quality. As a ﬁrst approach, we
estimated population average changes in FEV1 and FVC as
ml/year. As a second approach, we identiﬁed individuals with
excessive changes in FEV1 over time using SPIROLA
software [Hnizdo et al., 2010]. SPIROLA analyses of
longitudinal change in FEV1 are appropriate for both patterns
leading to restrictive or obstructive spirometry because FEV1
decreases in both patterns. For individuals with less than
8 years of follow-up, this program compares FEV1 values to
the limit of longitudinal decline (LLD). The LLD is a
threshold value used to determine whether the lung function
decline between the ﬁrst FEV1 value (or a mean of the ﬁrst
two observations, if the ﬁrst FEV1 value is lower than the
second one) and each follow-up FEV1 value is excessive.
Observations that fall below the LLD warrant concern as
having less than a 5% chance of being normal. Beginning
with 8 years of follow-up, SPIROLA bases the interpretation
of excessive decline on an individual’s regression slope and
the lower 95% conﬁdence limit around the regression line.
The SPIROLA software adjusts its determination of LLD
for spirometry quality, as reﬂected by mean pair-wise within-
person variation, in addition to considering what would be
normal declines in healthy persons. High quality spirometry
monitoring programs, often carried out for research purposes,
can achieve a within-person variation of approximately 3%
[Wang and Petsonk, 2004] or 4% [Wang et al., 2006]. We
determined that the employees’ spirometry data of A, B, and
C quality had a within-person variation of 5%. We used
SPIROLA to identify an LLD of 12.4% longitudinal decline
based on the relative within-person variation of 5% and a
referential rate of FEV1 decline of 30ml/year [Hnizdo
et al., 2010]. Supplemental on-line information for this paper
shows an illustrative example of SPIROLA plots.
Associations between Work History and
Lung Function
Using logistic regression, we modeled the categorical
outcomes of restrictive abnormalities on the most recent
spirometry test and having excessive FEV1 decline against
work area. We used multivariate linear regression models to
investigate the association of changes in FEV1 and FVC as
continuous variables with work area variables. For these
models, the outcome was the change in lung function in ml/
year that had been estimated for each individual. For both
types of models, we adjusted for body mass index of 30 or
more km/m2 at the last test, change in weight over the
spirometry testing period for each employee (as pounds per
year), age at last test, ever-smoking as a yes or no categorical
variable, and tenure in years. For the models using ever
worked in any speciﬁc area with higher potential for ﬂavoring
exposure, we used those who never worked in the areas with
higher potential for exposure to ﬂavoring chemicals as the
comparison group. Similarly, we compared current employ-
ees in any speciﬁc area with higher potential for exposure to
the employees not currently working in areas with higher
potential for exposure.
RESULTS
Demographics
The demographic characteristics of the 112 employees
with spirometry records are given in Table II. Those 97
employees with work history data showed that 42 currently
TABLE II. Demographic Characteristics for112 flavoringsmanufacturing
facility production employees at date ofmost recent spirometry test
Male gender, n (%) 96 (85.7)
Race, n (%)
White 86 (76.8)
Black 23 (20.5)
Hispanic 3 (2.7)
Ever smoker, n (% of108 employees) 42 (38.9)
Age in years, mean (range) 45.5 (21^67)
Tenure in years, mean (range for 95 employees) 16.2 (0.64^36.1)
Body mass index30 kg/m2, n (%) 33 (29.5)
132 Kreiss
worked in areas having higher potential for ﬂavoring
exposure (Table III), and 63 had ever worked in such areas.
Few spirometry measurements were made prior to 2004 (17
of 369), and the proportion of test sessions with A, B, or C
quality was 81.8%. The range of spirometry follow-up time
was 0 to 11 years; 28 employees had only one spirometry test.
Seventy of 84 had more than one spirometry test of A, B, or C
quality, of whom 63 had work history information that
included tenure. Of these 63, the group of 43 employees who
had ever worked in areas of higher potential for ﬂavoring
exposures had an average follow-up of 5.5 years, in
comparison to 3.6 years follow-up for the group of 20
employees always in areas with lower exposure potential.
The 28 employees who were currently working in areas of
higher potential for ﬂavoring exposure had an average of 5.6
years of follow-up, compared to 4.4 years of follow-up for the
35 employees with lower current potential for exposure.
Interpretation of Most Recent
Spirometry Tests
The most recent test was performed in 2009 for 96
employees, in 2008 for 12 employees, and between 2004 and
2006 for four employees. Forty-eight percent of the most
recent spirometry tests for each individual had A quality, 14%
had B quality, 18% had C quality, 18% had D quality, and 2%
had F quality. We interpreted 106 of the 112 tests (90 of A–C
quality and 16 of D quality with a normal interpretation). We
identiﬁed 34/106 (32%) employees as having abnormal
spirometry results. We found a restrictive pattern in 30/106
(28%) employees (22 mild abnormality, six moderate
abnormality, one moderately severe abnormality, and one
severe abnormality). Additionally, we identiﬁed two employ-
ees with mild obstruction, one employee with moderate
obstruction, and one with a very severe mixed pattern.
Employees with interpretable spirometry measurements and
smoking histories had 3.7 times the prevalence of abnormal
restriction compared to the U.S. population adjusted for age,
gender, race, ever smoking, and body mass index (95%
conﬁdence interval [CI] 2.6–5.3).
Changes in lung function over time
For non-smokers (n¼ 38), the mean decline in FEV1
was 81.3 (standard error [SE] 13.2) ml/year, and the mean
decline in FVCwas 94.8 (SE 16.9) ml/year. For ever smokers
(n¼ 30), these values were 94.5 (SE 25.3) ml/year for FEV1
and 125.1 (SE 32.8) ml/year for FVC. Results for percent
predicted FEV1 and FVC (which adjust for age) for the 18
employees tested for all four years from 2006 to 2009 showed
parallel declines in average percent predicted FEV1 and FVC
over time with relatively stable FEV1/FVC ratio (Fig. 1),
consistent with a tendency toward restriction.
Of 70 employees with two or more spirometry tests of A,
B, or C quality used in the SPIROLA analyses of abnormal
declines in FEV1, 13 (19%) were identiﬁed as having
excessive FEV1 declines using the 12.4% longitudinal
decline criterion. The employee with abnormal decline and
the shortest period of follow-up (1.9 years) lost 499ml/year,
for a total of 900ml in FEV1. The others with abnormal
declines in FEV1 had abnormal declines over 4.3–10.7 years
with annualized declines of 92–188ml/year. Of these 13
employees that had experienced abnormal rates of decline,
ﬁve continued to have FEV1 values in the normal range
at their most recent spirometry test. Eight (32%) of 25
TABLE III. Numbers of EmployeesWith Spirometry andWork History
Data byWork Area in FlavoringsManufacturing Plant
Work area
Number of
current employees
Number of
employees evera
Administration 0 6
Dry blendb 7 20
Extract and distillationb 0 1
Liquid compoundingb 22 47
Maintenance 7 16
Packaging 19 49
Process flavorsb 9 16
QC and R&Dc 12 20
Sample order 3 3
Spray dryb 4 8
Warehouse 14 27
Total 97
aIncludes current employees in addition to employees who had a previous assign-
ment in the area during their work tenure.
bIn our analyses, an area definedashavinghigher potential for flavoringexposure in
comparison to other work areas.
cQuality Control and Research and Development.
FIGURE1. Group means of percent predicted forced vital capacity (FVC) and forced
expiratory volume in 1 second (FEV1) and FEV1/FVC ratio (expressed as percent) by
year of test for all A^C quality spirometry tests for 18 employees tested 2006^2009. If
there was more than one test per worker in a year, the last test of the year was used.
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employees with both abnormal restrictive spirometry and
serial measurements had excessive decline in FEV1,
suggesting that the abnormality was progressing.
Associations between Work History and
Lung Function
Restriction on last spirometry showed no signiﬁcant
associations with work area (Table IV). Changes in FEV1 in
ml/year were signiﬁcantly associatedwith ever havingworked
in areas with higher potential for exposure to ﬂavorings. The
adjusted means for change in FEV1 for those ever having
worked in higher potential exposure areas versus those
never having worked in these areas were 115ml/year
compared to38ml/year (P¼ 0.015). Changes in FVC were
also higher in those ever working in higher potential for
exposure areas (adjusted means of 134ml/year vs. 56ml/
year; P¼ 0.057). Within the category of higher potential
for exposure, ever having worked in liquid compounding, as
compared to never having worked in areas with higher
potential for exposure, was associated with a larger decline
in FEV1 (adjusted means of 109ml/year vs. 40ml/year;
P¼ 0.024). Excessive decline in FEV1 was associated with
currently working in higher potential for exposure areas (odds
ratio¼ 5.8; 95% CI¼ 1.2–28.8, P¼ 0.032) and with ever
working in higher potential for exposure areas (odds
ratio¼ 7.0; 95% conﬁdence interval¼ 0.93–52.6,P¼ 0.059).
DISCUSSION
Burden of Occupational Lung Disease
Of production employees in the medical surveillance
program of this ﬂavoring manufacturing company, 37% had
either abnormal spirometry or abnormal declines in spirome-
try or both, with the predominant abnormality being a
restrictive pattern. Restriction was about 31 2= times more
common than expected compared to the general United States
population, after adjusting for potential contributing factors
such as smoking, overweight and obesity. Abnormal loss in
lung function during employment raises the possibility of an
employment-related cause of progressive decline. The
statistical associations that we have documented between
abnormal declines in lung function and persons in jobs with
higher potential for ﬂavorings exposures are consistent with
employment conditions causing deterioration in lung health.
The evidence in favor of work-relatedness is three-fold.
First, employees with higher potential for ﬂavorings exposure
in their work areas had 3.0 times greater annualized decline
in FEV1 than employees in jobs with lower potential for
exposure; 2.4 times greater annualized decline in FVC;
and the average yearly FEV1 decline was 3.8 times greater
than is normal in the general population (115 vs. 30ml/year).
Second, employees with current higher potential for
ﬂavorings exposure had 5.8 times the odds of abnormal
decline in FEV1 compared to employees with lower potential
for exposure. Because employees often relocate to other jobs
if they suspect health effects related to their work (“healthy
worker effect”), we evaluated whether employees that had
ever worked in areas with higher potential for ﬂavorings
exposure had higher risk of excessive decline compared to
employees that had never worked in such areas and found a
trend to even higher odds (7.0-fold) than was associated with
current employment in higher potential exposure jobs. Third,
within the higher potential for ﬂavorings exposure work
areas, we identiﬁed a single job group (those ever working in
liquid compounding) that had a statistically increased annual
FEV1 decline in comparison to employees that never worked
TABLE IV. Logistic Regression andMultiple Linear RegressionModels of Spirometric Outcomes in Relation toAreas Reflecting Different Potential
Flavoring Exposures
Work area
Logistic modelsa Multiple linear regression modelsa
Restrictive abnormality Excessive FEV1decline FEV1ml/yr decline FVC ml/yr decline
OR 95% CI OR 95% CI Adjusted mean Adjusted mean
Worked in areas with higher potential for exposure
Ever vs. never 1.1 0.34^3.43 7.0 0.93^52.6 115 vs.38 134 vs.56
Currently vs. not currently 0.58 0.19^1.76 5.8 1.2^28.8 110 vs.76 119 vs. 101
Worked in liquid compounding
Ever vs. never in areas of higher potential for exposure 1.1 0.31^3.70 3.6 0.51^26.02 109 vs.40 128 vs.62
Currently vs. not currently in areas of higher potential
for exposure
0.82 0.23^3.0 3.2 0.56^18.23 104 vs.75 113 vs.100
OR, odds ratio; CI, confidence interval; vs.,versus; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; ml, milliliters; yr,year.
aModelsadjustedforbodymassindexof30ormorekilograms/meter2,change inweightover thespirometry testingperiodforeachemployee (aspoundsperyear), ageat last
test, ever-smoking as a yes or no categorical variable, and tenure in years.
0.05< P 0.1.
P 0.05.
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in areas with higher potential ﬂavorings exposures. The liquid
compounding subgroup of employees was the largest among
those employees working in the ﬁve areas with higher
potential for ﬂavorings exposure, which conferred adequate
power to demonstrate an association with greater FEV1
decline in comparison to employees in areas with lower
potential for exposure.
Although excessive decline in lung function was
strongly associated with current work areas with higher
potential for ﬂavorings exposure, we found no statistical
association between restrictive abnormality and such work
areas. The 3.7-fold excess of restriction in the employee
population undergoing surveillance compared to the general
population was broadly distributed among all work areas. The
employees referred for spirometric testing were all thought to
have potential for ﬂavorings exposure. Indeed, IOSHA
testing in 2012 documented two high levels of diacetyl
exposure in packaging, which we had previously classiﬁed in
the lower potential for ﬂavorings exposure category [IOSHA,
2012]. The calculated concentrations were 0.05 ppm for a
STEL, based on 13min of sampling and 0.01 ppm for a TWA,
based on 92min of sampling (actual measurements were 0.06
and 0.07 ppm, respectively). In addition, company diacetyl
sampling in 2009 documented that measurable diacetyl
exposure was broadly distributed across all work areas
sampled, including the warehouse, packaging, and laborato-
ry, although geometric mean diacetyl measurements, where
available, were higher in areas that we had previously
classiﬁed as having higher potential for ﬂavorings exposure
[NIOSH, 2011a]. With batch operations of many different
ﬂavorings, representative sampling is unlikely in any small
ﬂavoring manufacturing data set. The maximum diacetyl
exposures documented in some of the employees working
in lower potential for exposure areas were in the range
associated with lung disease in microwave popcorn plant
employees [Kanwal et al., 2006]. Thus, our classiﬁcation into
areas with higher and lower potential for ﬂavorings exposure
did not preclude exposures that could have resulted in
spirometric abnormality, even if excessive decline in
spirometry was not evident in recent serial measurements.
With our analytic exclusion of body mass index, weight
gain, and spirometry quality as explanations for work-related
restrictive abnormalities, we suspect inﬂammatory or
scarring interstitial lung or bronchiolar disease in a substantial
fraction of company employees with abnormal spirometry. In
case series of biopsy-documented constrictive bronchiolitis,
cases frequently have normal spirometry; when abnormal,
spirometry can be restrictive, obstructive, or mixed restrictive
and obstructive in pattern [Markopoulou et al., 2002; Ghanei
et al., 2008; King et al., 2011]. In epidemiologic work to date
in microwave popcorn, other food production, and ﬂavoring
manufacturing industries, restrictive abnormalities have been
common in employees exposed to diacetyl among other
ﬂavoring chemicals [Kreiss, 2012]. Inhalation toxicology
documents epithelial necrosis in rodents exposed to diacetyl
or 2,3-pentanedione, consistent with the mechanism of
constrictive bronchiolitis in humans [Palmer et al., 2011;
Hubbs et al., 2012]. Inhalation toxicology does not exist for
many of the priority respiratory hazards of ﬂavoring
ingredients. Altogether, the risks of occupational lung disease
in this plant are considerable, and the ongoing employee
health burden is clear, particularly among employees with
higher potential for ﬂavoring exposures. To date, we do not
know the pathophysiology underlying the excess restriction
among these employees, which could be interstitial,
bronchiolar, or alveolar in location.
The literature on nonfatal and subacute hydrogen sulﬁde
exposures documents exertional dyspnea and both obstruc-
tive and restrictive effects, including organizing pneumonia
with a mixed pattern of obstructive and restrictive abnormal-
ities [Arnold et al., 1985; Parra et al., 1991; Richardson, 1995;
Hessel et al., 1997; Doujaiji and Al-Tawﬁq, 2010]. IOSHA
measured high levels of hydrogen sulﬁde in the reactions
area, which was adjacent to the packaging area in 2008,
but we are not certain how workers in this area would
have been classiﬁed among the 12 areas identiﬁed by the
company.
Potential Causal Exposures
Work-relatedness of the spirometric abnormalities does
not imply that diacetyl is the sole or primary cause. Flavoring
companies have hundreds of chemical exposures other than
diacetyl and its alpha-diketone substitutes. In the complex
exposure setting of batch operations of many different ﬂavor
formulations, each lasting a short time, teasing out single
causes of respiratory impairment may be impossible.
Fortunately, identifying the causative agent(s) is not required
to put preventive measures in place in ﬂavoring manufacture.
These include medical surveillance for respiratory com-
plaints, excessive interval pulmonary function declines, and
abnormal spirometry regardless of measured concentrations
of chemicals, only a few of which have exposure level
guidance.
Limitations
The company spirometric surveillance data had several
limitations. First, 19% of the spirometry records provided by
the company’s medical provider had D or F quality, and an
additional 18% had C quality, indicating marginal repeatabil-
ity of measurements within a test session. Our evaluation of
serial spirometry records may have underestimated abnormal
declines because we excluded poor quality spirometry, and
only 70 (63%) employees had serial tests with A, B, or C
quality. Thus, the 39 (37%) employees with either abnormal
spirometry (30 restricted, 3 obstructed, and 1 mixed), an
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isolated excessive decline in FEV1 (5), or both (8) may be an
underestimate of the number of employees with spirometric
ﬁndings suggestive of lung disease. The effect of comparison
of highest FEV1 and FVC for company employees with U.S.
population spirometry data that may have been of higher
quality is not knowable because quality scores post-dated the
NHANES III public dataset.
The work history information provided by the company
was incomplete and lacked details concerning tasks
associated with job titles or areas of production. Few
exposure measurements were available initially to support
our classiﬁcation of some areas as having higher potential for
ﬂavoring exposures than the remainder of jobs and areas.
These two data limitations may have resulted in misclassiﬁ-
cation of exposures and health outcomes, either of which
would lower our ability to detect possible work-related
associations. For example, we did not include laboratory,
maintenance, research and development and quality control,
and packaging employees in the group with higher potential
for exposure, although this classiﬁcation would be appropri-
ate in some other ﬂavoring or food production plants. Those
with spirometry data certainly were not an unexposed control
group, and exposures in all areas may have been sufﬁcient to
cause restrictive abnormalities. The company air sampling
data from 2009 provided some evidence that the areas that we
considered to have higher potential for ﬂavoring exposures
had higher diacetyl measurements [NIOSH, 2011a]. But
subsequent OSHA measurements documented notable
diacetyl exposures in packaging, which we had classiﬁed
in the lower potential exposure category. We don’t know
whether reactions area workers with high hydrogen sulﬁde
exposures were in the higher or lower potential for ﬂavorings
exposure group.
Finally, small numbers of employees in many production
categories limited statistical power to determine differences
among subgroups. We were able to demonstrate that employ-
ees that ever worked in liquid compounding had signiﬁcantly
greater declines in FEV1 compared to employees that had
never worked in areas with higher potential for exposures to
ﬂavorings. This statistical ﬁnding does not imply that
employees in other areas within the group of higher potential
exposure areas had no risk, nor does it mean that employees in
areas with lower potential for exposure had no risk. Indeed,
diacetyl has been measured by the company in all production
areas; all employees participating in medical surveillance were
thought to have potential ﬂavoring exposure; and approxi-
mately two-thirds of the employees with spirometry for whom
we had work history information had at some time worked in
areas classiﬁed as having higher potential for ﬂavorings
exposure. Together, these limitations may explain why we did
not ﬁnd an association between higher potential for exposure
areas and abnormal restrictive spirometry, despite ﬁnding
higher risk for excessive decline in recent spirometrymeasures
in relation to current exposure category.
Conclusions
Our ﬁnding that abnormal loss of lung function was not
uniformly distributed among company employees and was
concentrated among employees with higher potential for
ﬂavoring exposures is consistent with a work-related cause.
With the insensitivity of spirometry and lung volumes
in detecting both constrictive bronchiolitis [Markopoulou
et al., 2002; Ghanei et al., 2008; King et al., 2011] and clinical
restrictive disease [Boros et al., 2004], the burden of
occupational lung disease among these employees may be
far greater. Further medical testing of those with symptoms or
abnormalities in spirometry is of interest to deﬁne any lung
diseases resulting in restrictive spirometric abnormality in
this workplace. Frequent spirometric follow-up of the
workforce and those with excessive FEV1 decline may
assist in documenting whether workplace interventions to
lower ﬂavoring exposure are effective in preventing work-
associated declines in lung function. In the meantime, those
responsible for medical surveillance, diagnosis, and clinical
management of ﬂavoring-exposed workers need to take
account of the widening spectrum of occupational lung
disease presentation in both the food production and ﬂavoring
manufacturing industries.
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